Clinical Trial

Twiist Postmarket Surveillance Study for Type 1 Diabetes

Study acronym: twiist-PS
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this surveillance study is to collect real-world data on adults and youth with type 1 diabetes (T1D) using twiist(TM) for insulin delivery.
Trial Details
NCT Number NCT07356089
Lead Sponsor Deka Research and Development
Collaborators: Jaeb Center for Health Research
Conditions Type 1 Diabetes (T1D), Type 1 Diabetes Mellitus
Enrollment 1,875 participants
Start Date 2025-12-09
Primary Completion 2027-05-01 (estimated)
Study Completion 2028-05-01 (estimated)
Updated on ClinicalTrials.gov 2026-01-21